Medeon Biodesign (ROCO:6499) Institutional Ownership: 0.03% (As of Aug. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6499 Medeon Biodesign Inc ROCO:6499
61 GF Score
Price NT$66.80
GF Value NT$107.24
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Medeon Biodesign Institutional Ownership?

Medeon Biodesign ROCO:6499 +9.15% 61 Institutional Ownership is 0.03% as of Aug. 15, 2026. GuruFocus rates ROCO:6499 with a GF Score™ of 61/100 and a GF Value™ of NT$107.24 (Possible Value Trap). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Medeon Biodesign's institutional ownership is 0.03%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Medeon Biodesign's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Medeon Biodesign's Float Percentage Of Total Shares Outstanding is 0.00%.

Medeon Biodesign Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Medeon Biodesign's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medeon Biodesign Institutional Ownership Chart

Medeon Biodesign Historical Data

The historical data trend for Medeon Biodesign can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 0.09 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03
ROCO:6499
61GF Score
Medeon Biodesign Inc ROCO:6499
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medeon Biodesign Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.03% mean?
Medeon Biodesign (ROCO:6499) has a Institutional Ownership of 0.03% as of Aug. 15, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Medeon Biodesign and its competitors.
Is Medeon Biodesign's Institutional Ownership too high?
Medeon Biodesign's current Institutional Ownership is 0.03%. Overall, Medeon Biodesign has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medeon Biodesign's Institutional Ownership compare to ISRG and BDX?
Medeon Biodesign's Institutional Ownership of 0.03% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Medeon Biodesign and its competitors. Medeon Biodesign's current Institutional Ownership is 0.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medeon Biodesign stock overvalued right now?
Based on GuruFocus' analysis, Medeon Biodesign (ROCO:6499) is currently considered Possible Value Trap. The stock's GF Value™ is NT$107.24, compared to a current price of NT$66.80 — trading 37.7% below its estimated fair value. The current Institutional Ownership is 0.03%. Medeon Biodesign's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Medeon Biodesign (ROCO:6499), the current Institutional Ownership is 0.03% as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medeon Biodesign (ROCO:6499) Overvalued in 2026?

Based on GuruFocus' analysis, Medeon Biodesign stock appears to be undervalued. The current stock price of NT$66.80 is trading 37.7% below its estimated GF Value™ of NT$107.24. GuruFocus considers Medeon Biodesign to be Possible Value Trap.

Key valuation signals for ROCO:6499:

  • Institutional Ownership: 0.03%
  • GF Value™: NT$107.24 vs. price of NT$66.80 (37.7% below fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the ROCO:6499 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medeon Biodesign Business Description

Address No. 116, HouGang Street, 7th Floor, Shilin District, Taipei, TWN, 11170
Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.
61GF Score

Get the complete analysis for ROCO:6499

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$66.80
Price
NT$107.24
GF Value